Navigation Links
Kuvan Receives Priority Review Status From Health Canada
Date:6/10/2009

is in clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase 1/2 clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the continued development and commercialization of Kuvan and BioMarin's other products and product candidates and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: our success in the continued commercialization of Kuvan; the content and timing of decisions by the U.S. Food and Drug Administration, Health Canada and other regulatory authorities concerning each of the described products and product candidates; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K, as amended, and the factors contained in BioMarin's reports on Form 10-Q and Form 8-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R), Naglazyme(R) and Kuvan(R) are a registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(R) is a
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Kuvan Receives Positive Opinion From CHMP for European Approval
4. Kuvan Receives Marketing Approval in the European Union
5. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
10. IsoTis Receives FDA Clearance for Accell Family of Products
11. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Having access to safe drinking water and ensuring ... corners of the globe. It’s a major priority right ... where many have been sickened by unclean water. , ... of Engineering has been working to improve drinking water ... college for the peasants.” A branch university of the ...
(Date:10/31/2014)... 30, 2014 Caustic soda is utilized in ... polycarbonates. At present, China takes lead in the global caustic ... possesses a number of facilities in the USA, Germany, Brazil ... caustic soda market in terms of output and production capacities. ... on average by 3% per year in the years ahead. ...
(Date:10/31/2014)... The evening of October 29th, ... in successful medical device development to give its ... takes to successfully innovate in the complex and ... two-hour on-site class, Insight gave master’s program students ... School of Engineering, medical and law schools an ...
(Date:10/31/2014)... 30, 2014 Two separate delegations ... hosted by Charm Sciences at its Andover, Massachusetts ... in the US, the participants discussed international systems ... management, and process verification, and received hands-on technical ... was the first visit to the United States ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2
... Cingular merger with AT&T? , ,I've read the business stories ... the assets and customers of AT&T Wireless for $41 billion. ... 2 carrier Verizon by 9 million subscribers. The one hitch ... brand and plans to launch a new wireless service under ...
... Many organizations talk a good game about interpersonal skills, influence ... there's a pretty clear chain of command that runs right ... Technology (DoIT) at the University of Wisconsin-Madison, Annie Stunden ... that many more staff with IT responsibilities in other departments ...
... in Carlsbad, California. , Dynal : 400+ employees worldwide, ... in Oslo, Norway. Brown Deer, Wis. ... Dynal Biotech ASA , whose U.S. operations are based ... for $380.4 million. , ,Invitrogen has considered the ...
Cached Biology Technology:Cingular confusion 2Cingular confusion 3Annie Stunden, CIO at the University of Wisconsin-Madison 2Annie Stunden, CIO at the University of Wisconsin-Madison 3Annie Stunden, CIO at the University of Wisconsin-Madison 4Invitrogen to buy Norwegian biotech with operations in Brown Deer 2
(Date:10/29/2014)... on sunlight to make their food, but they also need ... scientists discovered a group of molecules in plants that shields ... Journal of the American Chemical Society , one team ... work. , Timothy Zwier and colleagues at Purdue University note ... can cause serious damage to plant DNA and, as a ...
(Date:10/29/2014)... available in German . ... Cabral and Peter Schlögelhofer at the Max F. Perutz ... Medical University of Vienna dived into the process of ... plants display an inversion of the standard meiotic phases. ... journal Nature Communications . , Meiosis is the ...
(Date:10/29/2014)... Ghrelin is a hormone released by the stomach and ... viewed as a psychoactive substance that primarily affects brain ... , This knowledge, combined with findings from animal ... the potential to stimulate alcohol craving. , Dr. Lorenzo ... found that, as they had anticipated, alcohol craving was ...
Breaking Biology News(10 mins):Meiotic cell division 'the other way round' 2Ghrelin stimulates an appetite for drinking alcohol 2
... it comes to improving bone health in postmenopausal women ... University researcher has found a simple, proactive solution to help ... career, I have tested numerous fruits, including figs, dates, strawberries ... having the effect on bone density that dried plums, or ...
... , INDIANAPOLIS -- An Indiana University scientist studying human ... the U.S. Department of Defense to study a chemical ... bone healing. Hiroki Yokota, professor of biomedical engineering ... of anatomy and cell biology at the IU School ...
... the first major survey in Asia of a deadly fungus ... worldwide. The massive survey could help scientists zero in on ... of the globe -- and why Asian amphibians have so ... chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis or Bd, is ...
Cached Biology News:No bones about it: Eating dried plums helps prevent fractures and osteoporosis 2New compound may accelerate bone healing, prevent osteoporosis 2New compound may accelerate bone healing, prevent osteoporosis 3Researchers complete first major survey of amphibian fungus in Asia 2
Latanoprost EIA Antiserum EIAs neutrophils antisera enzyme immunoassays reagents...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Phospho-SEK1/MKK4 (Thr261) Antibody...
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Biology Products: